Aytu BioPharma, Inc.AYTUNASDAQ
Loading
Operating Income ContractionContracting
Percentile Rank53
Studio
Year-over-Year Change

Profit from core business operations before interest and taxes

Latest
$-8.68M
↑ 69% vs avg
Percentile
P53
Within normal range
Streak
2 yr
Consecutive declineContracting
Average
$-28.17M
Historical baseline
PeriodValueYoY Change
TTM$-8.68M-10.8%
2025$-7.83M-392.0%
2024$-1.59M+90.7%
2023$-17.07M+84.5%
2022$-109.91M-86.7%
2021$-58.87M-178.6%
2020$-21.13M-25.4%
2019$-16.85M+14.5%
2018$-19.70M+2.1%
2017$-20.13M-